EW - Edwards Lifesciences Q4 2022 Earnings Preview

• Edwards Lifesciences ( NYSE: EW ) is scheduled to announce Q4 earnings results on Tuesday, January 31st, after market close.
• The consensus EPS Estimate is $0.61 (+19.6% Y/Y) and the consensus Revenue Estimate is $1.33B (flat Y/Y).
• Over the last 2 years, EW has beaten EPS estimates 50% of the time and has beaten revenue estimates 63% of the time.
• Over the last 3 months, EPS estimates have seen 0 upward revisions and 20 downward. Revenue estimates have seen 0 upward revisions and 18 downward.

For further details see: